Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or Without Hyperthermic IntraPEritoneal Chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part I: Preoperative and Intraoperative Management
Overview
Oncology
Authors
Affiliations
Background: Enhanced recovery after surgery (ERAS) pathways have been shown to considerably reduce complications, length of stay and costs after most of surgical procedures by standardised application of best evidence-based perioperative care. The aim was to elaborate dedicated recommendations for cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC) in a two-part series of guidelines based on expert consensus. The present part I of the guidelines highlights preoperative and intraoperative management.
Methods: The core group assembled a multidisciplinary panel of 24 experts involved in peritoneal surface malignancy surgery representing the fields of general surgery (n = 12), gynaecological surgery (n = 6), and anaesthesia (n = 6). Experts systematically reviewed and summarized the available evidence on 72 identified perioperative care items, following the GRADE (grading of recommendations, assessment, development, evaluation) system. Final consensus (defined as ≥50%, or ≥70% of weak/strong recommendations combined) was reached by a standardised 2-round Delphi process, regarding the strength of recommendations.
Results: Response rates were 100% for both Delphi rounds. Quality of evidence was evaluated high, moderate low and very low, for 15 (21%), 26 (36%), 29 (40%) and 2 items, respectively. Consensus was reached for 71/72(98.6%) items. Strong recommendations were defined for 37 items, No consensus could be reached regarding the preemptive use of fresh frozen plasma.
Conclusion: The present ERAS recommendations for CRS±HIPEC are based on a standardised expert consensus process providing clinicians with valuable guidance. There is an urgent need to produce high quality studies for CRS±HIPEC and to prospectively evaluate recommendations in clinical practice.
Alaswad M, Arabi T, Alshahrani A, Sabbah B, Jaamour H, AlOtry A World J Surg Oncol. 2025; 23(1):62.
PMID: 39987135 PMC: 11846258. DOI: 10.1186/s12957-025-03678-5.
LAcqua C, Frassanito L, Kusamura S, Valenza F J Anesth Analg Crit Care. 2025; 5(1):4.
PMID: 39844207 PMC: 11752816. DOI: 10.1186/s44158-025-00225-2.
Prakash Bhandoria G, Guru A, Pawar A, Bhatt A, Kumar N, Kumar R Gynecol Oncol Rep. 2025; 57():101662.
PMID: 39811827 PMC: 11732209. DOI: 10.1016/j.gore.2024.101662.
Lal Solanki S, Agarwal V, Ambulkar R, Joshi M, Chawathey S, Rudrappa S Crit Care Res Pract. 2025; 2024:8815211.
PMID: 39760061 PMC: 11698608. DOI: 10.1155/ccrp/8815211.
Asian Biomed (Res Rev News). 2024; 18(6):244-245.
PMID: 39697219 PMC: 11650589. DOI: 10.2478/abm-2024-0032.